Antibiotic dosing in critically ill patients with septic shock and on continuous renal replacement therapy: Can we resolve this problem with pharmacokinetic studies and dosing guidelines?

Critical Care

Volumn 18, Issue 3, 2014, Pages

  Roberts, Jason A ^a,b,c   Roberts, Darren M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM; CEFTRIAXONE; MEROPENEM; PIPERACILLIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACUTE KIDNEY FAILURE; ANTIBIOTIC THERAPY; CONTINUOUS RENAL REPLACEMENT THERAPY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DRUG CLEARANCE; DRUG DOSE REGIMEN; DRUG EXCRETION; DRUG MONITORING; EXTRACORPOREAL OXYGENATION; HEMODIALYSIS; HUMAN; INTENSIVIST; KIDNEY FUNCTION; NOTE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SEPTIC SHOCK; UPREGULATION; RENAL REPLACEMENT THERAPY; SHOCK, SEPTIC;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CRITICAL ILLNESS; HUMANS; RENAL REPLACEMENT THERAPY; SHOCK, SEPTIC;

EID: 84904709098     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13939     Document Type: Note

References (14)

1. Ulldemolins M, Vaquer S, Llaurado-Serra M, Pontes C, Calvo G, Soy D, Martin-Loeches I. Beta lactam dosing in critically ill patient with septic shock and continuous renal replacement therapy. Crit Care 2014, 18:227.
2. Shekar K, Roberts JA, Ghassabian S, Mullany DV, Wallis SC, Smith MT, Fraser JF. Altered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: cause for concern?. J Antimicrob Chemother 2013, 68:726-727. 10.1093/jac/dks435, 23111850.
3. Udy AA, Roberts JA, Boots RJ, Paterson DL, Lipman J. Augmented renal clearance: implications for antibacterial dosing in the critically ill. Clin Pharmacokinet 2010, 49:1-16. 10.2165/11318140-000000000-00000, 20000886.
4. Blot S, Lipman J, Roberts DM, Roberts JA. The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?. Diagn Microbiol Infect Dis 2014, 79:77-84. 10.1016/j.diagmicrobio.2014.01.015, 24602849.
5. Seyler L, Cotton F, Taccone FS, De Backer D, Macours P, Vincent JL, Jacobs F. Recommended beta-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy. Crit Care 2011, 15:R137. 10.1186/cc10257, 3219006, 21649882.
6. Roberts DM, Roberts JA, Roberts MS, Liu X, Cole CL, Nair P, Lipman J, Bellomo R. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy - a multicentre pharmacokinetic study. Crit Care Med 2012, 40:1523-1528. 10.1097/CCM.0b013e318241e553, 22511133.
7. Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten HM, Ronco C, Kellum JA, . Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2007, 2:431-439. 10.2215/CJN.03681106, 17699448, Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators.
8. Wong G, Briscoe S, Adnan S, McWhinney B, Ungerer J, Lipman J, Roberts JA. Protein binding of beta-lactam antibiotics in critically ill patients: can we successfully predict unbound concentrations?. Antimicrob Agents Chemother 2013, 57:6165-6170. 10.1128/AAC.00951-13, 3837907, 24080664.
9. Ulldemolins M, Roberts JA, Rello J, Paterson DL, Lipman J. The effects of hypoalbuminaemia on optimising antibiotic dosing in critically ill patients. Clin Pharmacokinet 2011, 50:99-110. 10.2165/11539220-000000000-00000, 21142293.
10. Brogard JM, Jehl F, Blickle JF, Dorner M, Arnaud JP, Monteil H. Biliary pharmacokinetic profile of piperacillin: experimental data and evaluation in man. Int J Clin Pharmacol Ther Toxicol 1990, 28:462-470.
11. Jamal JA, Udy AA, Lipman J, Roberts JA. The impact of variation in renal replacement therapy settings on piperacillin, meropenem, and vancomycin drug clearance in the critically ill: an analysis of published literature and dosing regimens. Crit Care Med 2014, Mar 26 [Epub ahead of print].
12. Choi G, Gomersall CD, Tian Q, Joynt GM, Freebairn R, Lipman J. Principles of antibacterial dosing in continuous renal replacement therapy. Crit Care Med 2009, 37:2268-2282. 10.1097/CCM.0b013e3181aab3d0, 19487930.
13. Sime FB, Roberts MS, Peake SL, Lipman J, Roberts JA. Does beta-lactam pharmacokinetic variability in critically ill patients justify therapeutic drug monitoring? A systematic review. Ann Intensive Care 2012, 2:35. 10.1186/2110-5820-2-35, 3460787, 22839761.
14. Roberts JA, Hope WW, Lipman J. Therapeutic drug monitoring of beta-lactams for critically ill patients: unwarranted or essential?. Int J Antimicrob Agents 2010, 35:419-420. 10.1016/j.ijantimicag.2010.01.022, 20189777.